Clinical Trials Directory

Trials / Completed

CompletedNCT02203435

The Patient Characteristics and Mortality of Code Blue Calls

The Characteristics of the Blue-code Calls; Five Years Survey.

Status
Completed
Phase
Study type
Observational
Enrollment
1,050 (actual)
Sponsor
Gulsah Karaoren · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study aimed to retrospectively examine patients evaluated by the Code Blue team on a Code Blue call in our hospital between 2009 and 2013. Primary outcome: an examination of the survival rates and demographic data of the patients evaluated as an emergency by a Code Blue call in the period 2009-2013.Secondary outcome: to determine the rates of false Code Blue calls, the clinics giving Code Blue calls and the relationship between the times of Code Blue calls and mortality.Inclusion criteria: patients throughout the whole hospital for whom a Code Blue form was completed and who were evaluated by the Code Blue team on a Code Blue call. Exclusion criteria: patients who refused treatment

Detailed description

Retrospective examination was made of the Code Blue notification forms which were completed by the anaesthesiologist as Code Blue team leader of the hospital. The age of the patient, gender, diagnosis, the department where admitted, time of Blue Code call, reason for Blue Code call, whether or not the Blue code call was appropriate, whether or not cardiopulmonary resuscitation was administered, if administered, the duration of cardiopulmonary resuscitation, whether or not the patient was postoperative, whether or not the patient had been discharged from the intensive care unit and if so, how many days had passed, the APACHE II score of the patient and expected mortality, were recorded by calculation of the data on thhe Code Blue notification form and in the hospital automated system. Patients were excluded from the study if they had refused treatment or if there was no record of the parameters necessary to calculate the APACHE II score.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2014-07-29
Last updated
2014-08-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02203435. Inclusion in this directory is not an endorsement.